RemedyAtlas
Back

Colloidal Silver

unproven antimicrobial claims and potential for toxicity

supplement
Human trial evidenceTraditional useInteraction riskNeeds more research

Suspended silver particles historically used for antimicrobial purposes.

Colloidal silver refers to a suspension of microscopic silver particles in a liquid. Historically, silver has been recognized for its antimicrobial properties. In modern times, colloidal silver has been marketed as a dietary supplement for various health conditions, often with claims of immune support or antimicrobial action. However, the scientific evidence supporting these health claims is largely absent or insufficient. The use of colloidal silver can also pose significant health risks, particularly with long-term or high-dose exposure.

Quick answer

What it is: Colloidal silver refers to a suspension of microscopic silver particles in a liquid.

May support:Chronic Sinusitis

Evidence Summary

There is a lack of high-quality clinical trials in humans to support the efficacy of colloidal silver for any health condition. Most claims are based on in vitro studies or anecdotal reports, which are insufficient to establish therapeutic benefits or safety.

Last reviewed · Jun 2026

Have you tried Colloidal Silver?

Vote in 5 seconds. Add details if you want.

Your experience for Chronic Sinusitis:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

See Community Mentions

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Colloidal Silver

Search on Reddit →

Latest News

Latest news on Colloidal Silver

More on Google News →

Health Videos

Health videos on Colloidal Silver

More on YouTube

Why It Works

Disrupts microbial enzyme function — efficacy and safety contested.

How it works in more detail

Silver ions (Ag+) are thought to be the active antimicrobial component. These ions may bind to bacterial cell membranes, altering their permeability and leading to cell lysis. They can also interact with proteins and nucleic acids within the cell, disrupting metabolic pathways, enzyme activity, and DNA replication. This broad-spectrum activity has been observed against various bacteria, fungi, and viruses in laboratory settings. However, the efficacy and safety of ingesting colloidal silver for these effects in humans are not supported by clinical evidence.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
Use with caution; no established safe dose
Typical forms
liquid suspension, spray
Quality markers
Given the lack of proven efficacy and significant safety concerns, quality markers are less relevant. However, if considering such products, consumers might look for products that specify particle size, concentration (ppm), and purity, though these do not guarantee safety or effectiveness.
Medication interactions
  • Antibiotics (e.g., tetracyclines, quinolones)
  • Thyroid medications (e.g., levothyroxine)
Avoid if
  • Pregnant or breastfeeding
  • Known kidney disease
  • Taking certain medications (see interactions)
  • Children

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

Use with caution; no established safe dose

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Silver nanoparticles, silver ions (Ag+)

Traditional use

Silver has been used historically for its antimicrobial properties, with ancient civilizations using silver vessels to store water and applying silver to wounds. In the late 19th and early 20th centuries, silver compounds were used medically before the advent of modern antibiotics. However, these historical uses do not equate to the safety or efficacy of modern colloidal silver products for internal consumption.

Safety

Safety warnings

Risk of argyria (skin discoloration); efficacy unproven.

Avoid if

  • Pregnant or breastfeeding
  • Known kidney disease
  • Taking certain medications (see interactions)
  • Children

Medication interactions

  • Antibiotics (e.g., tetracyclines, quinolones)
  • Thyroid medications (e.g., levothyroxine)

Reported side effects

  • Argyria (bluish-gray skin discoloration)
  • Kidney damage
  • Neurological problems (e.g., seizures)
  • Digestive upset
  • Headache
  • Fatigue

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade

There is a lack of high-quality clinical trials in humans to support the efficacy of colloidal silver for any health condition. Most claims are based on in vitro studies or anecdotal reports, which are insufficient to establish therapeutic benefits or safety.

Clinical Trial Registries(1)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality

  • Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.

    n=548 · NCT06603688 · UNKNOWN · UNKNOWN

    The aim of this study is to evaluate the efficacy and safety of a quadruple therapy consisting of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate for the first phase eradication of Helicobacter pylori. Assuming that the quadruple therapy of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate is no less effective than the bismuth containing quadruple therapy of amoxicillin and clarithromycin. Patients diagnosed with Helicobacter pylori infection will be randomly assigned to one of the aforementioned treatments. During the 6-week follow-up, urea breath test, rapid urease test, or Helicobacter pylori fecal antigen test will be performed to confirm eradication. The aim of this study is to evaluate the efficacy and safety of a quadruple therapy consisting of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate for the first phase eradication of Helicobacter pylori. Assuming that the quadruple therapy of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate is no less effective than the bismuth containing quadruple therapy of amoxicillin and clarithromycin. Patients diagnosed with Helicobacter pylori infection will be randomly assigned to one of the aforementioned treatments. During the 6-week follow-up, urea breath test, rapid urease test, or Helicobacter pylori fecal antigen test will be performed to confirm eradication.

    Clinical TrialClinicalTrials.govModerate Quality

Limitations: The primary limitation is the absence of well-designed, placebo-controlled human clinical trials. Existing research is often limited to laboratory studies or animal models, which do not translate reliably to human outcomes. There is also a lack of standardization in colloidal silver products, making it difficult to compare any limited research findings.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Colloidal Silver?

Help others see what actually works.